NCT02045355

Brief Summary

Health effects of fish consumption have been demonstrated in epidemiological studies and in controlled intervention studies in a number of different population groups, however, randomized controlled studies on the effect of fish consumption in elderly are sparse. Many studies have focused on n-3 fatty acids instead of fish as a food and therefore, many health effects have only been related to the effect of n- 3 fatty acids. The elderly are a heterogeneous population group and therefore difficult to study. In order to reduce heterogeneity, it is advisable to focus on elderly with specific needs. Elderly who experienced a hip fracture can serve as a model for an advanced ageing process, as these patients typically experience a huge inflammatory response, immobilisation and a reduction in muscle mass. Increased fish intake is believed to have effects towards inflammation and a reduction in muscle mass. Therefore, we want to test whether increased fish intake can have positive health effects in elderly who experienced a hip fracture. Main hypothesis: Increased fish intake (salmon, cod, pelagic fish), in comparison to meat, will increase mobility, muscle strength and mobility in frail elderly. Objectives

  1. 1.To evaluate the health effects of fish consumption in frail elderly The effect of a dietary intervention with fish on mobility, muscle mass and strength in elderly who experienced a hip fracture has not been shown before.
  2. 2.To demonstrate the feasibility of dietary intervention in elderly We want to show that a dietary intervention with fish or control meals is feasible in elderly. The meals (4 portions of fish per week or control portions of meat) will be delivered to their homes.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2014

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 17, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 24, 2014

Completed
8 days until next milestone

Study Start

First participant enrolled

February 1, 2014

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2016

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
Last Updated

December 14, 2015

Status Verified

December 1, 2015

Enrollment Period

1.9 years

First QC Date

January 17, 2014

Last Update Submit

December 11, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in New Mobility Score (NMS)

    The NMS is an easy, reliable tool for the assessment of mobility. It is based on three questions, which are scored with 0 to 3, thus the result will be between 0 and 9 points.

    Baseline and 16 weeks

Secondary Outcomes (4)

  • Change of muscle mass

    Baseline and 16 weeks

  • Change in Vitamin D status

    Baseline and 16 weeks

  • Change of muscle strength

    Baseline and 16 weeks

  • Change of self-perceived health

    Recruitment and 4 months

Other Outcomes (3)

  • Change in inflammation

    Baseline and 16 weeks

  • Change of dietary habits

    Baseline and 16 weeks

  • Number of falls during intervention period

    16 weeks

Study Arms (2)

Fish intervention

EXPERIMENTAL

The patients will receive one portion of salmon (150 g), one portion of cod (150 g), and two portions of sild (50g each) per week.

Other: Fish intervention

Meat control group

NO INTERVENTION

The control food will be pork and chicken (150 g each) and two portions of cooked ham / liver pate for use in cold meals (50 g each).

Interventions

The intervention will compare fish intake with a correspondent amount of meat. The basis for the comparison will be the estimated protein intake from fish and meat and should be almost similar both from fish and from meat. To ensure compliance and to add more variety to the diet, different fish types will be included in the intervention group and different meat sources in the control group. The types of fish (and that of meat in the control diet) that will be used will be accurately documented and will be similar for all participants included.

Fish intervention

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Patients \>65 years with a first hip fracture who have a reasonable high chance of returning to their homes after rehabilitation,
  • with a sufficient cognitive function to understand the objectives of the study
  • the ability to go / walk without support of a person prior to the hip fracture.
  • the life expectancy should be more than 6 months.
  • the ability to use the provided food and willingness to participate
  • sign the informed consent.

You may not qualify if:

  • Patients are excluded who will probably not return to their home but to a nursing home.
  • Patients who lack the cognitive function to understand the study objectives
  • Patients with a missing informed consent
  • Patients with reduced life expectancy of less than 6 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Haukeland University Hospital

Bergen, Hordaland, 5020, Norway

Location

Haraldsplass Deacon Hospital

Bergen, Hordaland, 5892, Norway

Location

Related Publications (1)

  • Parker MJ, Palmer CR. A new mobility score for predicting mortality after hip fracture. J Bone Joint Surg Br. 1993 Sep;75(5):797-8. doi: 10.1302/0301-620X.75B5.8376443.

    PMID: 8376443BACKGROUND

MeSH Terms

Conditions

SarcopeniaHip Fractures

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and SymptomsFemoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg Injuries

Study Officials

  • Jutta Dierkes

    Departmente of Clinical Medicine, University of Bergen

    PRINCIPAL INVESTIGATOR
  • Oddrun A Gudbrandsen

    Department of Clinical Medicine, University of Bergen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 17, 2014

First Posted

January 24, 2014

Study Start

February 1, 2014

Primary Completion

January 1, 2016

Study Completion

January 1, 2017

Last Updated

December 14, 2015

Record last verified: 2015-12

Locations